Cargando…

Serum Metabolomic Alterations Associated with Cesium-137 Internal Emitter Delivered in Various Dose Rates

Our laboratory and others have use radiation metabolomics to assess responses in order to develop biomarkers reflecting exposure and level of injury. To expand the types of exposure and compare to previously published results, metabolomic analysis has been carried out using serum samples from mice e...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Heng-Hong, Lin, Yun-Tien, Laiakis, Evagelia C., Goudarzi, Maryam, Weber, Waylon, Fornace, Albert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407308/
https://www.ncbi.nlm.nih.gov/pubmed/32629836
http://dx.doi.org/10.3390/metabo10070270
_version_ 1783567597401276416
author Li, Heng-Hong
Lin, Yun-Tien
Laiakis, Evagelia C.
Goudarzi, Maryam
Weber, Waylon
Fornace, Albert J.
author_facet Li, Heng-Hong
Lin, Yun-Tien
Laiakis, Evagelia C.
Goudarzi, Maryam
Weber, Waylon
Fornace, Albert J.
author_sort Li, Heng-Hong
collection PubMed
description Our laboratory and others have use radiation metabolomics to assess responses in order to develop biomarkers reflecting exposure and level of injury. To expand the types of exposure and compare to previously published results, metabolomic analysis has been carried out using serum samples from mice exposed to (137)Cs internal emitters. Animals were injected intraperitoneally with (137)CsCl solutions of varying radioactivity, and the absorbed doses were calculated. To determine the dose rate effect, serum samples were collected at 2, 3, 5, 7, and 14 days after injection. Based on the time for each group receiving the cumulative dose of 4 Gy, the dose rate for each group was determined. The dose rates analyzed were 0.16 Gy/day (low), 0.69 Gy/day (medium), and 1.25 Gy/day (high). The results indicated that at a cumulative dose of 4 Gy, the low dose rate group had the least number of statistically significantly differential spectral features. Some identified metabolites showed common changes for different dose rates. For example, significantly altered levels of oleamide and sphingosine 1-phosphate were seen in all three groups. On the other hand, the intensity of three amino acids, Isoleucine, Phenylalanine and Arginine, significantly decreased only in the medium dose rate group. These findings have the potential to be used in assessing the exposure and the biological effects of internal emitters.
format Online
Article
Text
id pubmed-7407308
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74073082020-08-11 Serum Metabolomic Alterations Associated with Cesium-137 Internal Emitter Delivered in Various Dose Rates Li, Heng-Hong Lin, Yun-Tien Laiakis, Evagelia C. Goudarzi, Maryam Weber, Waylon Fornace, Albert J. Metabolites Article Our laboratory and others have use radiation metabolomics to assess responses in order to develop biomarkers reflecting exposure and level of injury. To expand the types of exposure and compare to previously published results, metabolomic analysis has been carried out using serum samples from mice exposed to (137)Cs internal emitters. Animals were injected intraperitoneally with (137)CsCl solutions of varying radioactivity, and the absorbed doses were calculated. To determine the dose rate effect, serum samples were collected at 2, 3, 5, 7, and 14 days after injection. Based on the time for each group receiving the cumulative dose of 4 Gy, the dose rate for each group was determined. The dose rates analyzed were 0.16 Gy/day (low), 0.69 Gy/day (medium), and 1.25 Gy/day (high). The results indicated that at a cumulative dose of 4 Gy, the low dose rate group had the least number of statistically significantly differential spectral features. Some identified metabolites showed common changes for different dose rates. For example, significantly altered levels of oleamide and sphingosine 1-phosphate were seen in all three groups. On the other hand, the intensity of three amino acids, Isoleucine, Phenylalanine and Arginine, significantly decreased only in the medium dose rate group. These findings have the potential to be used in assessing the exposure and the biological effects of internal emitters. MDPI 2020-06-30 /pmc/articles/PMC7407308/ /pubmed/32629836 http://dx.doi.org/10.3390/metabo10070270 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Li, Heng-Hong
Lin, Yun-Tien
Laiakis, Evagelia C.
Goudarzi, Maryam
Weber, Waylon
Fornace, Albert J.
Serum Metabolomic Alterations Associated with Cesium-137 Internal Emitter Delivered in Various Dose Rates
title Serum Metabolomic Alterations Associated with Cesium-137 Internal Emitter Delivered in Various Dose Rates
title_full Serum Metabolomic Alterations Associated with Cesium-137 Internal Emitter Delivered in Various Dose Rates
title_fullStr Serum Metabolomic Alterations Associated with Cesium-137 Internal Emitter Delivered in Various Dose Rates
title_full_unstemmed Serum Metabolomic Alterations Associated with Cesium-137 Internal Emitter Delivered in Various Dose Rates
title_short Serum Metabolomic Alterations Associated with Cesium-137 Internal Emitter Delivered in Various Dose Rates
title_sort serum metabolomic alterations associated with cesium-137 internal emitter delivered in various dose rates
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407308/
https://www.ncbi.nlm.nih.gov/pubmed/32629836
http://dx.doi.org/10.3390/metabo10070270
work_keys_str_mv AT lihenghong serummetabolomicalterationsassociatedwithcesium137internalemitterdeliveredinvariousdoserates
AT linyuntien serummetabolomicalterationsassociatedwithcesium137internalemitterdeliveredinvariousdoserates
AT laiakisevageliac serummetabolomicalterationsassociatedwithcesium137internalemitterdeliveredinvariousdoserates
AT goudarzimaryam serummetabolomicalterationsassociatedwithcesium137internalemitterdeliveredinvariousdoserates
AT weberwaylon serummetabolomicalterationsassociatedwithcesium137internalemitterdeliveredinvariousdoserates
AT fornacealbertj serummetabolomicalterationsassociatedwithcesium137internalemitterdeliveredinvariousdoserates